8.40
Anika Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
4.41
FY23:
−1.79
FY24:
5.40
FY25:
11.2
Change from FY21 to FY25
millions USD
FY21:
−3.12
FY22:
−7.49
FY23:
−5.43
FY24:
−8.33
FY25:
−0.40
Change from FY21 to FY25
millions USD
FY21:
−6.78
FY22:
−4.85
FY23:
−6.32
FY24:
−12.7
FY25:
−10.6
millions USD
FY21:
−1.43
FY22:
−8.06
FY23:
−13.5
FY24:
−15.7
FY25:
0.32
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.25
FY22:
−3.08
FY23:
−7.22
FY24:
−2.33
FY25:
4.36
All amounts in millions USD